Structural connectivity profile of scans without evidence of dopaminergic deficit (SWEDD) patients compared to normal controls and Parkinson’s disease patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-1801
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Structural connectivity profile of scans without evidence of dopaminergic deficit (SWEDD) patients compared to normal controls and Parkinson’s disease patients ; volume:5 ; number:1 ; day:26 ; month:8 ; year:2016 ; pages:1-15 ; date:12.2016
SpringerPlus ; 5, Heft 1 (26.8.2016), 1-15, 12.2016
- Creator
-
Kim, Mansu
- Contributor
-
Park, Hyunjin
SpringerLink (Online service)
- DOI
-
10.1186/s40064-016-3110-8
- URN
-
urn:nbn:de:1111-201609248696
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kim, Mansu
- Park, Hyunjin
- SpringerLink (Online service)
Other Objects (12)
Clinical characteristics of fatigued Parkinson’s patients and the response to dopaminergic treatment
Unraveling connectivity changes due to dopaminergic therapy in chronically treated Parkinson’s disease patients
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Whole-genome DNA hyper-methylation in iPSC-derived dopaminergic neurons from Parkinson’s disease patients
Aberrant epigenome in iPSC ‐derived dopaminergic neurons from Parkinson's disease patients
Dopaminergic denervation and associated MRI microstructural changes in the nigrostriatal projection in early Parkinson’s disease patients
Synaptic dysfunction and extracellular matrix dysregulation in dopaminergic neurons from sporadic and E326K-GBA1 Parkinson’s disease patients
Speech Characteristics of Patients with Parkinson's Disease—Does Dopaminergic Medications Have a Role?
Clinical Manifestations of Subjective Sleep Disorders in Chinese Patients with Parkinson’s Disease and Their Relationship with Dopaminergic Drugs
Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
Drug therapy in patients with Parkinson’s disease
Clinical characteristics of fatigued Parkinson’s patients and the response to dopaminergic treatment
Unraveling connectivity changes due to dopaminergic therapy in chronically treated Parkinson’s disease patients
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Whole-genome DNA hyper-methylation in iPSC-derived dopaminergic neurons from Parkinson’s disease patients
Aberrant epigenome in iPSC ‐derived dopaminergic neurons from Parkinson's disease patients
Dopaminergic denervation and associated MRI microstructural changes in the nigrostriatal projection in early Parkinson’s disease patients
Synaptic dysfunction and extracellular matrix dysregulation in dopaminergic neurons from sporadic and E326K-GBA1 Parkinson’s disease patients
Speech Characteristics of Patients with Parkinson's Disease—Does Dopaminergic Medications Have a Role?
Clinical Manifestations of Subjective Sleep Disorders in Chinese Patients with Parkinson’s Disease and Their Relationship with Dopaminergic Drugs
Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
Drug therapy in patients with Parkinson’s disease
Clinical characteristics of fatigued Parkinson’s patients and the response to dopaminergic treatment
Unraveling connectivity changes due to dopaminergic therapy in chronically treated Parkinson’s disease patients
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Whole-genome DNA hyper-methylation in iPSC-derived dopaminergic neurons from Parkinson’s disease patients
Aberrant epigenome in iPSC ‐derived dopaminergic neurons from Parkinson's disease patients
Dopaminergic denervation and associated MRI microstructural changes in the nigrostriatal projection in early Parkinson’s disease patients
Synaptic dysfunction and extracellular matrix dysregulation in dopaminergic neurons from sporadic and E326K-GBA1 Parkinson’s disease patients
Speech Characteristics of Patients with Parkinson's Disease—Does Dopaminergic Medications Have a Role?
Clinical Manifestations of Subjective Sleep Disorders in Chinese Patients with Parkinson’s Disease and Their Relationship with Dopaminergic Drugs
Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?